Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433128
Status:
AVAILABLE
Last Update Posted:
2024-05-29
First Post:
2024-05-22
Brief Title:
Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
Sponsor:
Basilea Pharmaceutica
Organization:
Basilea Pharmaceutica
Organization Data
Organization:
Basilea Pharmaceutica
Class:
INDUSTRY
Study ID:
EAP to Fosmanogepix
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Basilea Pharmaceutica
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None